Protalix Biotherapeutics, Inc. (PLX)
2.59
-0.02
(-0.77%)
USD |
NYAM |
Oct 30, 16:00
2.59
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics Total Return Level : 2.59 for Oct. 30, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 30, 2026 | 2.59 |
| October 29, 2026 | 2.61 |
| October 28, 2026 | 2.59 |
| October 27, 2026 | 2.53 |
| October 26, 2026 | 2.48 |
| October 23, 2026 | 2.55 |
| October 22, 2026 | 2.57 |
| October 21, 2026 | 2.57 |
| October 20, 2026 | 2.64 |
| October 19, 2026 | 2.56 |
| October 16, 2026 | 2.62 |
| October 15, 2026 | 2.70 |
| October 14, 2026 | 2.61 |
| October 13, 2026 | 2.75 |
| October 12, 2026 | 2.78 |
| October 09, 2026 | 2.78 |
| October 08, 2026 | 2.70 |
| October 07, 2026 | 2.71 |
| October 06, 2026 | 2.73 |
| October 05, 2026 | 2.71 |
| October 02, 2026 | 2.71 |
| October 01, 2026 | 2.68 |
| September 30, 2026 | 2.76 |
| September 29, 2026 | 2.69 |
| September 28, 2026 | 2.69 |
| Date | Value |
|---|---|
| September 25, 2026 | 2.72 |
| September 24, 2026 | 2.75 |
| September 23, 2026 | 2.80 |
| September 22, 2026 | 2.84 |
| September 21, 2026 | 2.75 |
| September 18, 2026 | 2.69 |
| September 17, 2026 | 2.70 |
| September 16, 2026 | 2.68 |
| September 15, 2026 | 2.66 |
| September 14, 2026 | 2.77 |
| September 11, 2026 | 2.64 |
| September 10, 2026 | 2.73 |
| September 09, 2026 | 2.67 |
| September 08, 2026 | 2.65 |
| September 04, 2026 | 2.67 |
| September 03, 2026 | 2.62 |
| September 02, 2026 | 2.59 |
| September 01, 2026 | 2.59 |
| August 31, 2026 | 2.57 |
| August 28, 2026 | 2.54 |
| August 27, 2026 | 2.61 |
| August 26, 2026 | 2.48 |
| August 25, 2026 | 2.40 |
| August 24, 2026 | 2.41 |
| August 21, 2026 | 2.38 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Altimmune, Inc. | 7.918 |
| Taysha Gene Therapies, Inc. | 4.13 |
| Humacyte, Inc. | 0.4112 |
| Agenus, Inc. | 6.84 |
| Amgen, Inc. | 697.82 |